NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Reshape Biotech

Reshape Biotech

Private
CopenhagenHealthcare & Life Scienceshttps://reshapebiotech.com/

Last Round

Series A

Apr 9, 2024

Est. Valuation

$1.79M

Total Funding Raised

$29.23M

Company Overview

Reshape Biotech is a biotechnology company that develops an AI and robotics-powered platform to automate laboratory experiments for the food, agriculture, and biotech sectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Workflow Automation, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

laboratory automationmicrobiology automationlab roboticsbiotech automationhardware-as-a-serviceHaaScomputer visionmicrobial screeningautomated colony pickinghigh-throughput screeningHTSlab-on-a-chipsynthetic biology toolsdigital biologyautomated plate reader

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Reshape Biotech Comparables

Compare Reshape Biotech with similar companies based on industry and business-model similarity.

Reshape Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Singer Instruments
80%
Microtechnix
79%
Automata
78%

Reshape Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 9, 2024
SeedFeb 9, 2023
Pre SeedMay 23, 2021
AcceleratorMar 23, 2021

Key People

Founding team and executive leadership

Carl-Emil Grøn

CEO Co-founder

Founding Team

Lasse Byrner

Chief Operating Officer

Executive Team

Reshape Biotech Investors

Notable investors and investment history

Reshape Biotech investors
InvestorRounds
Astanor VenturesSeries A
R7 PartnersSeries A
Y CombinatorAccelerator, Seed, Series A, Pre Seed
Sherpa CapitalSeries A, Seed
Look Up VenturesSeed
FundersClubSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 8, 2025

    Added Ventera Bio, a biotechnology startup, as a customer.

Reshape Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Reshape Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Reshape Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Employee Range64
Year Founded2018
Last FundingApr 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.